{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:02:03Z","timestamp":1788314523728,"version":"build-2803163510"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Midazolam is a benzodiazepine sedative used in NICUs. Because benzodiazepine\u2019s effects include respiratory depression and potential detrimental developmental effects, minimizing exposure could benefit neonates. Dexmedetomidine is routinely used for sedation in older pediatric populations. We implemented a quality improvement initiative with the aim of decreasing midazolam infusions by 20% through use of dexmedetomidine.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A multidisciplinary committee created a sedation guideline that included standardized dexmedetomidine dosing escalation and weaning. Baseline data collection occurred from January 2015 to February 2018, with intervention from March 2018 to December 2019. Percentage of sedation episodes with dexmedetomidine initiated was followed as a process measure. Outcomes measures were percentage of eligible infants receiving midazolam infusions and midazolam-free days per sedation episode. Bradycardia with dexmedetomidine, unplanned extubation rates, and morphine dosage were monitored as balancing measures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Our study included 434 episodes of sedation in 386 patients. Dexmedetomidine initiation increased from 18% to 49%. The intervention was associated with a significant reduction in midazolam initiation by 30%, from 95% to 65%, with special cause variation on statistical process control chart analysis. Midazolam-free days per sedation episode increased from 0.3 to 2.2 days, and patients receiving dexmedetomidine had lower midazolam doses (1.3 mg\/kg per day versus 2.2 mg\/kg per day, P = 5.97 \u00d7 10\u221204). Bradycardia requiring discontinuation of dexmedetomidine, unplanned extubation rates, and morphine doses were unchanged.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Implementation of a quality improvement initiative was successful in reducing the percentage of patients receiving midazolam infusions and increased midazolam-free days per sedation episode, revealing an overall reduction in benzodiazepine exposure while maintaining adequate sedation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2020-041566","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T08:29:36Z","timestamp":1633422576000},"source":"Crossref","is-referenced-by-count":26,"title":["Reducing Benzodiazepine Exposure by Instituting a Guideline for Dexmedetomidine Usage in the NICU"],"prefix":"10.1542","volume":"148","author":[{"given":"Sarah U.","family":"Morton","sequence":"first","affiliation":[{"name":"Division of Newborn Medicine, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Labrecque","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Moline","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hansen","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Leeman","sequence":"additional","affiliation":[{"name":"Division of Newborn Medicine, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Harvard University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"2022010419372637300_B1","unstructured":"FDA Drug Safety Communication\n          . FDA approves label changes for use of general anesthetic and sedation drugs in young children. Available at: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-approves-label-changes-use-general-anesthetic-and-sedation-drugs. Accessed October 24, 2020"},{"issue":"4","key":"2022010419372637300_B2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/ALN.0000000000002047","article-title":"Exposure of developing brain to general anesthesia: what is the animal evidence?","volume":"128","author":"Jevtovic-Todorovic","year":"2018","journal-title":"Anesthesiology"},{"issue":"11","key":"2022010419372637300_B3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn.2016.128","article-title":"Lasting impact of general anaesthesia on the brain: mechanisms and relevance","volume":"17","author":"Vutskits","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2022010419372637300_B4","doi-asserted-by":"crossref","first-page":"e0105","DOI":"10.1097\/CCE.0000000000000105","article-title":"Potential neurodevelopmental effects of pediatric intensive care sedation and analgesia: repetitive benzodiazepine and opioid exposure alters expression of glial and synaptic proteins in juvenile rats","volume":"2","author":"Iqbal O\u2019Meara","year":"2020","journal-title":"Crit Care Explor"},{"issue":"6","key":"2022010419372637300_B5","first-page":"CD002052","article-title":"Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit","volume":"2012","author":"Ng","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022010419372637300_B6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.earlhumdev.2017.04.003","article-title":"Neurodevelopmental outcomes of neonates undergoing surgery under general anesthesia for malrotation of intestines","volume":"109","author":"Birajdar","year":"2017","journal-title":"Early Hum Dev"},{"issue":"4","key":"2022010419372637300_B7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/ana.24601","article-title":"Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants","volume":"79","author":"Duerden","year":"2016","journal-title":"Ann Neurol"},{"issue":"8","key":"2022010419372637300_B8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin Pharmacokinet"},{"issue":"26","key":"2022010419372637300_B9","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1056\/NEJMoa1904710","article-title":"Early sedation with dexmedetomidine in critically ill patients","volume":"380","author":"Shehabi","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"2022010419372637300_B10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000542-199212000-00013","article-title":"Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate","volume":"77","author":"Belleville","year":"1992","journal-title":"Anesthesiology"},{"issue":"2","key":"2022010419372637300_B11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-199108000-00013","article-title":"Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist","volume":"75","author":"Guo","year":"1991","journal-title":"Anesthesiology"},{"issue":"1\u20132","key":"2022010419372637300_B12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90744-3","article-title":"Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist","volume":"150","author":"Virtanen","year":"1988","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2022010419372637300_B13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000539-200003000-00035","article-title":"Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions","volume":"90","author":"Hall","year":"2000","journal-title":"Anesth Analg"},{"issue":"5","key":"2022010419372637300_B14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00007611-200405000-00007","article-title":"Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam","volume":"97","author":"Tobias","year":"2004","journal-title":"South Med J"},{"issue":"3","key":"2022010419372637300_B15","first-page":"320","article-title":"Dexmedetomidine in the pediatric population: a review","volume":"81","author":"Plambech","year":"2015","journal-title":"Minerva Anestesiol"},{"issue":"2","key":"2022010419372637300_B16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/pan.12030","article-title":"Efficacy and safety of intraoperative dexmedetomidine for acute postoperative pain in children: a meta-analysis of randomized controlled trials","volume":"23","author":"Schnabel","year":"2013","journal-title":"Paediatr Anaesth"},{"issue":"12","key":"2022010419372637300_B17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/PCC.0000000000000941","article-title":"Dexmedetomidine use in critically ill children with acute respiratory failure","volume":"17","author":"Grant","year":"2016","journal-title":"Pediatr Crit Care Med"},{"issue":"5","key":"2022010419372637300_B18","doi-asserted-by":"crossref","first-page":"e013858","DOI":"10.1136\/bmjopen-2016-013858","article-title":"Effectiveness of \u03b12 agonists for sedation in paediatric critical care: study protocol for a retrospective cohort observational study","volume":"7","author":"Hayden","year":"2017","journal-title":"BMJ Open"},{"issue":"10","key":"2022010419372637300_B19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1345\/aph.1M245","article-title":"Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate","volume":"43","author":"O\u2019Mara","year":"2009","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2022010419372637300_B20","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1055\/s-0038-1669938","article-title":"Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience","volume":"8","author":"O\u2019Mara","year":"2018","journal-title":"AJP Rep"},{"issue":"8","key":"2022010419372637300_B21","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/pan.13454","article-title":"Intranasal dexmedetomidine, as midazolam-sparing drug, for MRI in preterm neonates","volume":"28","author":"Bua","year":"2018","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"2022010419372637300_B22","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/pan.13110","article-title":"Dexmedetomidine sedation combined with caudal anesthesia for lower abdominal and extremity surgery in ex-preterm and full-term infants","volume":"27","author":"Waurick","year":"2017","journal-title":"Paediatr Anaesth"},{"issue":"5","key":"2022010419372637300_B23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1060028018812089","article-title":"Dexmedetomidine use in a tertiary care NICU: a descriptive study","volume":"53","author":"Dersch-Mills","year":"2019","journal-title":"Ann Pharmacother"},{"key":"2022010419372637300_B24","first-page":"2582965","article-title":"Dexmedetomidine pharmacokinetics in neonates with hypoxic-ischemic encephalopathy receiving hypothermia","volume":"2020","author":"McAdams","year":"2020","journal-title":"Anesthesiol Res Pract"},{"issue":"2","key":"2022010419372637300_B25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpeds.2013.10.002","article-title":"A phase II\/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates","volume":"164","author":"Chrysostomou","year":"2014","journal-title":"J Pediatr"},{"issue":"3","key":"2022010419372637300_B26","first-page":"252","article-title":"Dexmedetomidine versus standard therapy with fentanyl for sedation in mechanically ventilated premature neonates","volume":"17","author":"O\u2019Mara","year":"2012","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"6","key":"2022010419372637300_B27","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1213\/ane.0b013e3181733fdb","article-title":"General anesthetics induce apoptotic neurodegeneration in the neonatal rat spinal cord","volume":"106","author":"Sanders","year":"2008","journal-title":"Anesth Analg"},{"issue":"2","key":"2022010419372637300_B28","first-page":"524","article-title":"The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats","volume":"96","author":"Engelhard","year":"2003","journal-title":"Anesth Analg"},{"issue":"3","key":"2022010419372637300_B29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000542-199609000-00014","article-title":"Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices","volume":"85","author":"Talke","year":"1996","journal-title":"Anesthesiology"},{"issue":"1","key":"2022010419372637300_B30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2217\/pme-2019-0003","article-title":"Dexmedetomidine improves neurodevelopment and cognitive impairment in infants with congenital heart disease","volume":"17","author":"Huang","year":"2020","journal-title":"Per Med"},{"issue":"2","key":"2022010419372637300_B31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/pan.13553","article-title":"A systematic review and narrative synthesis on the histological and neurobehavioral long-term effects of dexmedetomidine","volume":"29","author":"van Hoorn","year":"2019","journal-title":"Paediatr Anaesth"},{"key":"2022010419372637300_B32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ntt.2017.01.001","article-title":"Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon","volume":"60","author":"Alam","year":"2017","journal-title":"Neurotoxicol Teratol"},{"issue":"2","key":"2022010419372637300_B33","doi-asserted-by":"crossref","first-page":"e0171498","DOI":"10.1371\/journal.pone.0171498","article-title":"Neuroprotective effects of dexmedetomidine against hyperoxia-induced injury in the developing rat brain","volume":"12","author":"Endesfelder","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"2022010419372637300_B34","doi-asserted-by":"crossref","first-page":"e20150463","DOI":"10.1542\/peds.2015-0463","article-title":"Preterm versus term children: analysis of sedation\/anesthesia adverse events and longitudinal risk","volume":"137","author":"Havidich","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"2022010419372637300_B35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00246-015-1110-z","article-title":"A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation","volume":"36","author":"Jiang","year":"2015","journal-title":"Pediatr Cardiol"},{"issue":"4","key":"2022010419372637300_B36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PCC.0000000000001451","article-title":"Dexmedetomidine as single continuous sedative during noninvasive ventilation: typical usage, hemodynamic effects, and withdrawal","volume":"19","author":"Shutes","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2022010419372637300_B37","first-page":"227","article-title":"Dexmedetomidine for the management of postoperative pain and sedation in newborns","volume":"24","author":"Sellas","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"2","key":"2022010419372637300_B38","first-page":"112","article-title":"Characterization of dexmedetomidine dosing and safety in neonates and infants","volume":"20","author":"Estkowski","year":"2015","journal-title":"J Pediatr Pharmacol Ther"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-041566\/1228307\/peds_2020041566.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2020-041566\/1228307\/peds_2020041566.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T19:38:00Z","timestamp":1641325080000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/148\/5\/e2020041566\/181698\/Reducing-Benzodiazepine-Exposure-by-Instituting-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,11,1]]},"published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2020-041566","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"e2020041566"}}